|
|
Volumn 68, Issue 4, 2002, Pages 220-225
|
|
Prostate-specific antigen dynamics predict risk of progression in advanced prostate cancer treated with bicalutamide plus castration
|
|
Author keywords
Advanced prostate cancer; Bicalutamide; Castration; Combined androgen blockade; Goserelin acetate; Prostate specific antigen
|
|
Indexed keywords
ANDROGEN;
ANTINEOPLASTIC AGENT;
BICALUTAMIDE;
GOSERELIN;
PROSTATE SPECIFIC ANTIGEN;
ANILIDE;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER SURGERY;
CASTRATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TOLERABILITY;
GASTROENTERITIS;
GASTROINTESTINAL SYMPTOM;
HAZARD ASSESSMENT;
HEMATOMA;
HUMAN;
IMPOTENCE;
MAJOR CLINICAL STUDY;
MALE;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROSTATE CARCINOMA;
PROTEIN BLOOD LEVEL;
SKIN ALLERGY;
VERTIGO;
BLOOD;
DISEASE COURSE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
ORCHIECTOMY;
PATHOLOGY;
PREDICTION AND FORECASTING;
PROSTATE TUMOR;
RISK FACTOR;
TIME;
AGED;
AGED, 80 AND OVER;
ANILIDES;
ANTINEOPLASTIC AGENTS;
COMBINED MODALITY THERAPY;
DISEASE PROGRESSION;
GOSERELIN;
HUMAN;
MALE;
MIDDLE AGE;
ORCHIECTOMY;
PREDICTIVE VALUE OF TESTS;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
RISK FACTORS;
TIME FACTORS;
HUMANS;
MIDDLE AGED;
|
|
EID: 0036016962
PISSN: 00421138
EISSN: None
Source Type: Journal
DOI: 10.1159/000058439 Document Type: Article |
|
Times cited : (2)
|
|
References (16)
|
